Lenalidomide Plus Melphalan as a Preparative Regimen for Autologous Stem Cell Transplantation in Relapsed Multiple Myeloma: A Phase 1 / 2 Study
Clinical trial NCT01054196 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT01054196
- Sponsor
- Weill Medical College of Cornell University
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2010-08-01
- Primary completion
- 2021-10-01
- Enrollment
- 52
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.